A study has demonstrated that AGP1 is an indicator of tubular disorder in multiple myeloma [42], and another has shown that serum and urinary AGP1 levels are elevated in type 2 diabetic patients with kidney disorders [5, 7]. Here, ORM1 is linked to AL amyloidosis.